TABLE 1.

Number of insulin products in the public and private sectors by the type of insulin, manufacturer, and presentation. Prices, Availability, and Affordability survey, Pakistan, 2019.

Characteristics		Public (n = 57) (N)	Private (n = 263) (N)	Total found in both sectors (n = 320) (N)	Total found (%)
Type of insulin	Human insulin
	Short-acting human insulin	24	51	75	23.4
	Intermediate-acting human insulin	9	38	47	14.6
	Mixed human insulin	24	68	92	28.7
	Analog insulin
	Rapid-acting analog insulin	0	30	30	9.3
	Long-acting analog insulin	0	41	41	12.8
	Mixed analog insulin	0	35	35	10.9
Manufacturer	Eli Lilly	26	104	130	40.6
	Novo Nordisk	26	88	114	35.6
	Sanofi-Aventis	0	32	32	10.0
	Getz Pharma, Pakistan	5	26	31	9.6
	Highnoon Labs, Pakistan	0	5	5	1.5
	Julphar, UAE	0	4	4	1.2
	Zafa, Pakistan	0	3	3	0.9
	PharmEvo, Pakistan	0	1	1	0.3
Presentation	Vial	57	130	187	58.4
	Prefilled Pen	0	95	95	29.6
	Cartridge	0	38	38	11.8